Calendar Finch Therapeutics Group, Inc.

Equities

FNCH

US31773D2009

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.32 USD +3.57% Intraday chart for Finch Therapeutics Group, Inc. +3.57% -35.73%

Chart calendar Finch Therapeutics Group, Inc.

d543e48e31bafc1fc7e6aa.dad_MP4hqpg-B13z1N06ExRTP_HyXM6qTDU_VwwXNMs.BeoVe7JX-_NZajCRor8IfER-R6iCbqLfGXBeFHxWc6gt9TxFhBHe7XlpGA~9368858cff6cd74177a858576e5fa44a

Upcoming events on Finch Therapeutics Group, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)

Past events on Finch Therapeutics Group, Inc.

2023-06-10 10:30 am Annual General Meeting
2023-05-10 07:00 am Q1 2023 Earnings Release
2023-03-23 04:05 pm Q4 2022 Earnings Release
2022-12-01 11:20 am Evercore ISI HealthCONx Conference
2022-11-16 05:55 am Jefferies London Healthcare Conference
2022-11-10 07:00 am Q3 2022 Earnings Release
2022-08-11 07:00 am Interim 2022 Earnings Release
2022-06-15 02:00 pm JMP Securities Life Sciences Conference
2022-06-10 10:30 am Annual General Meeting
2022-06-10 08:00 am Jefferies Healthcare Conference
2022-05-24 07:00 am H.C. Wainwright Global Life Sciences Investment Conference
2022-05-16 08:00 am Business Update Call
2022-05-16 07:00 am Q1 2022 Earnings Release
2022-03-31 04:56 pm FY 2021 Earnings Release
2022-03-01 03:15 pm Chardan Metagenomics and Microbiome Medicines Summit - Panel
2022-01-13 09:45 am JP Morgan Healthcare Conference
2022-01-10 07:00 am H.C. Wainwright BioConnect Conference
2021-12-02 10:05 am Evercore ISI HealthCONx Conference
2021-11-18 03:00 am Jefferies London Healthcare Conference - Pre- Recorded
2021-11-10 07:05 am Q3 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
7,72


18,5
20,2
-8.32%
0,86
1,30
-33.77%
EBITDA
Million USD
Released
Forecast
Spread
0,00


-57,7
-77,3
25.39%
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-60,0
-67,0
10.41%
-95,1
-103
7.65%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-115
-104
-10.34%
Net income
Million USD
Released
Forecast
Spread
0,00


-58,2
-67,0
13.14%
-115
-104
-10.34%
EPS
USD
Released
Forecast
Spread
-9,90


-44,4
-51,5
13.7%
-72,0
-66,9
-7.62%
Announcement Date26/02/2131/03/2223/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales
Million USD
Released
Forecast
Spread
0,81
5,00
-83.88%



0,36
1,30
-72.23%
0,14
1,50
-90.8%
0,01
0,40
-98%
0,11
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread






-20,4
-22,0
7.47%












EBIT
Million USD
Released
Forecast
Spread
-19,1
-15,0
-27.08%



-21,7
-19,9
-9.45%
-21,3
-18,9
-12.72%
-27,5
-15,2
-80.98%
-18,1
-4,10
-341.41%
-9,08
-7,30
-24.38%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






-22,7
-17,7
-28.25%
-40,4
-19,8
-103.89%
-27,0
-16,3
-65.69%
-67,4
-4,10
-1543.9%
-6,95
-7,30
4.79%
Net income
Million USD
Released
Forecast
Spread
-19,1
-15,0
-27.03%
-24,6


-22,7
-19,9
-14.36%
-40,4
-18,9
-113.6%
-27,0
-16,3
-65.69%
-63,9
-4,10
-1459.49%
-6,95
-7,30
4.79%
EPS
USD
Released
Forecast
Spread
-12,0
-9,60
-25%
-15,6


-14,4
-12,5
-15.66%
-25,5
-12,0
-112.5%
-16,8
-10,2
-64.71%
-39,9
-2,70
-1377.78%
-4,33
-4,50
3.78%
Announcement Date31/03/2216/05/2211/08/2210/11/2223/03/2310/05/2310/08/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. FNCH Stock
  4. Calendar Finch Therapeutics Group, Inc.